Innovate UK

Type

Other

Status

Active

Location

Swindon, United Kingdom

Total investments

975

Average round size

815K

Portfolio companies

780

Rounds per year

57.35

Lead investments

236

Follow on index

0.20

Exits

35

Stages of investment
Grant
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceMachine LearningHealth CareManufacturingMedical DeviceMedicalLife Science

Summary

Innovate UK appeared to be the Corporate Investor, which was created in 2007. The fund was located in Europe if to be more exact in United Kingdom. The main department of described Corporate Investor is located in the Swindon.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Software, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight F2G, Sky Medical Technology, Genomics. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Innovate UK, startups are often financed by Newable Private Investing, Mercia Fund Managers, Scottish Investment Bank. The meaningful sponsors for the fund in investment in the same round are SBRI Healthcare, Wayra, Longwall Venture Partners. In the next rounds fund is usually obtained by Entrepreneur First, EASME - EU Executive Agency for SMEs, Oxford Technology Management.

The higher amount of exits for fund were in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund. The average startup value when the investment from Innovate UK is 100 thousands - 1 million dollars. This Innovate UK works on 25 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this Corporate Investor is 43 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 13-24 deals per year. The important activity for fund was in 2018.

The overall number of key employees were 6.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
975
Lead investments
236
Exits
35
Rounds per year
57.35
Follow on index
0.20
Investments by industry
  • Health Care (242)
  • Biotechnology (173)
  • Software (168)
  • Medical Device (122)
  • Medical (116)
  • Show 382 more
Investments by region
  • United Kingdom (894)
  • United States (20)
  • Israel (3)
  • Spain (3)
  • Austria (2)
  • Show 10 more
Peak activity year
2023
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
2M
Group Appearance index
0.13
Avg. company exit year
15
Avg. multiplicator
1.24
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Fuse Diagnostics 29 May 2024 Seed 2M Cambridgeshire, Cambridge, United Kingdom
Scintam Engineering 26 Sep 2023 Manufacturing, Machinery Manufacturing Seed England, Nottingham, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.